Issue Highlights - November 2018
Update: 2018-12-06
Description
Endoscopist-related factors, rather than biology, are more likely to account for interval cancers in the proximal colon. New data suggest that Crohn's patients have greater risk of high-risk HPV infection and thus may benefit from anal cancer screening. New study on the factors associated with response to placebo in IBD patients has implications for clinical trial design. Research finds an association between the grade of acute on chronic liver failure and response to terlipressin and albumin in hepatorenal syndrome.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
